Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Retatrutide may have an edge for weight loss because it targets three hormone receptors instead of two
BPC 157 is studied for its potential to support tissue repair by influencing several biological processes that normally occur after injury
Accessing retatrutide outside of clinical trials typically involves research chemical suppliers whose products lack the quality assurance of pharmaceutical manufacturing
Risks to be aware of with peptides While many peptides may be considered generally safe when used under medical supervision, there are risks attached to them that users should educate themselves on
GSEA was performed using the clusterProfiler and msigdbr R packages ( Heatmaps were generated using Morpheus (Broad Institute)
Weeks 12: 2 mg once weekly Weeks 34: 4 mg once weekly Weeks 58: 8 mg once weekly Week 9+: 12 mg once weekly Efficacy and safety: The reason for the slow and gradual dosing protocol The Phase 2 clinical trial of retatrutide demonstrated that participants receiving the highest dose (12 mg) achieved up to 24% weight reduction after 48 weeks
US$ 29.56
US$ 25.58
US$ 28.15
US$ 29.01
US$ 27.33
US$ 28.67
US$ 25.49
US$ 20.25
US$ 24.68
US$ 27.27
US$ 29.52
